Chantal B E M Reusken

InstitutionNational Institute for Public Health and the Environment
Addressthe
Netherlands
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 23 Covid-19 publications, with a maximum of 3 publications in June 2020
    All Publications
    Bar chart showing 146 publications over 19 distinct years, with a maximum of 17 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Reukers DFM, van Boven M, Meijer A, Rots N, Reusken C, Roof I, van Gageldonk-Lafeber AB, van der Hoek W, van den Hof S. High Infection Secondary Attack Rates of Severe Acute Respiratory Syndrome Coronavirus 2 in Dutch Households Revealed by Dense Sampling. Clin Infect Dis. 2022 01 07; 74(1):52-58. PMID: 33822007.
      Citations: 5     Fields:    Translation:Humans
    2. van den Beld MJC, Murk JL, Kluytmans J, Koopmans MPG, Reimerink J, van Loo IHM, Wegdam-Blans MCA, Zaaijer H, GeurtsvanKessel C, Reusken C. Increasing the Efficiency of a National Laboratory Response to COVID-19: a Nationwide Multicenter Evaluation of 47 Commercial SARS-CoV-2 Immunoassays by 41 Laboratories. J Clin Microbiol. 2021 08 18; 59(9):e0076721. PMID: 34191578.
      Citations:    Fields:    Translation:HumansPHPublic Health
    3. Nguyen D, Simmonds P, Steenhuis M, Wouters E, Desmecht D, Garigliany M, Romano M, Barbezange C, Maes P, Van Holm B, Mendoza J, Oyonarte S, Fomsgaard A, Lassaunière R, Zusinaite E, Resman Rus K, Avšic-Županc T, Reimerink JH, Brouwer F, Hoogerwerf M, Reusken CB, Grodeland G, Le Cam S, Gallian P, Amroun A, Brisbarre N, Martinaud C, Leparc Goffart I, Schrezenmeier H, Feys HB, van der Schoot CE, Harvala H. SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data. Euro Surveill. 2021 07; 26(27). PMID: 34240697.
      Citations: 3     Fields:    Translation:Humans
    4. O'Toole Á, Hill V, Pybus OG, Watts A, Bogoch II, Khan K, Messina JP, Tegally H, Lessells RR, Giandhari J, Pillay S, Tumedi KA, Nyepetsi G, Kebabonye M, Matsheka M, Mine M, Tokajian S, Hassan H, Salloum T, Merhi G, Koweyes J, Geoghegan JL, de Ligt J, Ren X, Storey M, Freed NE, Pattabiraman C, Prasad P, Desai AS, Vasanthapuram R, Schulz TF, Steinbrück L, Stadler T, Parisi A, Bianco A, García de Viedma D, Buenestado-Serrano S, Borges V, Isidro J, Duarte S, Gomes JP, Zuckerman NS, Mandelboim M, Mor O, Seemann T, Arnott A, Draper J, Gall M, Rawlinson W, Deveson I, Schlebusch S, McMahon J, Leong L, Lim CK, Chironna M, Loconsole D, Bal A, Josset L, Holmes E, St George K, Lasek-Nesselquist E, et al. Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2. Wellcome Open Res. 2021; 6:121. PMID: 34095513.
      Citations: 25     
    5. Steenhuis M, van Mierlo G, Derksen NI, Ooijevaar-de Heer P, Kruithof S, Loeff FL, Berkhout LC, Linty F, Reusken C, Reimerink J, Hogema B, Zaaijer H, van de Watering L, Swaneveld F, van Gils MJ, Bosch BJ, van Ham SM, Ten Brinke A, Vidarsson G, van der Schoot EC, Rispens T. Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors. Clin Transl Immunology. 2021; 10(5):e1285. PMID: 34026115.
      Citations: 3     
    6. Bergmans BJM, Reusken CBEM, van Oudheusden AJG, Godeke GJ, Bonacic Marinovic AA, de Vries E, Kluiters-de Hingh YCM, Vingerhoets R, Berrevoets MAH, Verweij JJ, Nieman AE, Reimerink J, Murk JL, Swart A. Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort. Diagn Microbiol Infect Dis. 2021 Oct; 101(2):115392. PMID: 34161880.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    7. Stanoeva KR, van der Eijk AA, Meijer A, Kortbeek LM, Koopmans MPG, Reusken CBEM. Towards a sensitive and accurate interpretation of molecular testing for SARS-CoV-2: a rapid review of 264 studies. Euro Surveill. 2021 03; 26(10). PMID: 33706863.
      Citations:    Fields:    Translation:Humans
    8. Fischer C, Mögling R, Melidou A, Kühne A, Oliveira-Filho EF, Wolff T, Reiche J, Broberg E, Drosten C, Meijer A, Leitmeyer K, Leitmeyer K, Drexler JF, Reusken CBEM. Variable Sensitivity of SARS-CoV-2 Molecular Detection in European Expert Laboratories: External Quality Assessment, June and July 2020. J Clin Microbiol. 2021 02 18; 59(3). PMID: 33298612.
      Citations: 3     Fields:    Translation:HumansCells
    9. Welkers MRA, Han AX, Reusken CBEM, Eggink D. Possible host-adaptation of SARS-CoV-2 due to improved ACE2 receptor binding in mink. Virus Evol. 2021 Jan; 7(1):veaa094. PMID: 33500787.
      Citations: 18     
    10. van Tol S, Mögling R, Li W, Godeke GJ, Swart A, Bergmans B, Brandenburg A, Kremer K, Murk JL, van Beek J, Wintermans B, Reimerink J, Bosch BJ, Reusken C. Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach. Emerg Microbes Infect. 2020 Dec; 9(1):1965-1973. PMID: 32819220.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    11. Meyer B, Reimerink J, Torriani G, Brouwer F, Godeke GJ, Yerly S, Hoogerwerf M, Vuilleumier N, Kaiser L, Eckerle I, Reusken C. Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT). Emerg Microbes Infect. 2020 Dec; 9(1):2394-2403. PMID: 33043818.
      Citations: 32     Fields:    Translation:HumansCellsPHPublic Health
    12. Slot E, Hogema BM, Reusken CBEM, Reimerink JH, Molier M, Karregat JHM, IJlst J, Novotný VMJ, van Lier RAW, Zaaijer HL. Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands. Nat Commun. 2020 11 12; 11(1):5744. PMID: 33184284.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
    13. Rijkers G, Murk JL, Wintermans B, van Looy B, van den Berge M, Veenemans J, Stohr J, Reusken C, van der Pol P, Reimerink J. Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections. J Infect Dis. 2020 09 14; 222(8):1265-1269. PMID: 32726417.
      Citations: 37     Fields:    Translation:HumansCellsPHPublic Health
    14. Okba NMA, Müller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E, Chandler FD, Yazdanpanah Y, Le Hingrat Q, Descamps D, Houhou-Fidouh N, Reusken CBEM, Bosch BJ, Drosten C, Koopmans MPG, Haagmans BL. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients. Emerg Infect Dis. 2020 Jul; 26(7):1478-1488. PMID: 32267220.
      Citations: 586     Fields:    Translation:HumansCellsPHPublic Health
    15. Thijsen S, Heron M, Gremmels H, van der Kieft R, Reusken C, Kremer K, Limonard G, Bossink A. Elevated nucleoprotein-induced interferon-? release in COVID-19 patients detected in a SARS-CoV-2 enzyme-linked immunosorbent spot assay. J Infect. 2020 09; 81(3):452-482. PMID: 32540458.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    16. van der Hoek W, Backer JA, Bodewes R, Friesema I, Meijer A, Pijnacker R, Reukers DFM, Reusken C, Roof I, Rots N, Te Wierik MJM, van Gageldonk-Lafeber AB, Waegemaekers CHFM, van den Hof S. [The role of children in the transmission of SARS-CoV-2]. Ned Tijdschr Geneeskd. 2020 06 03; 164. PMID: 32749807.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    17. Mögling R, Meijer A, Berginc N, Bruisten S, Charrel R, Coutard B, Eckerle I, Enouf V, Hungnes O, Korukluoglu G, Kossyvakis T, Mentis A, Molenkamp R, Muradrasoli S, Papa A, Pigny F, Thirion L, van der Werf S, Reusken C. Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination. Emerg Infect Dis. 2020 08; 26(8):1944-1946. PMID: 32433015.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    18. van Kasteren PB, van der Veer B, van den Brink S, Wijsman L, de Jonge J, van den Brandt A, Molenkamp R, Reusken CBEM, Meijer A. Comparison of seven commercial RT-PCR diagnostic kits for COVID-19. J Clin Virol. 2020 07; 128:104412. PMID: 32416600.
      Citations: 134     Fields:    Translation:HumansCellsPHPublic Health
    19. Reusken CB, Buiting A, Bleeker-Rovers C, Diederen B, Hooiveld M, Friesema I, Koopmans M, Kortbeek T, Lutgens SP, Meijer A, Murk JL, Overdevest I, Trienekens T, Timen A, Van den Bijllaardt W, Van Dissel J, Van Gageldonk-Lafeber A, Van der Vegt D, Wever PC, Van der Hoek W, Kluytmans J. Rapid assessment of regional SARS-CoV-2 community transmission through a convenience sample of healthcare workers, the Netherlands, March 2020. Euro Surveill. 2020 03; 25(12). PMID: 32234115.
      Citations: 43     Fields:    Translation:HumansCellsPHPublic Health
    20. Reusken CBEM, Broberg EK, Haagmans B, Meijer A, Corman VM, Papa A, Charrel R, Drosten C, Koopmans M, Leitmeyer K, Leitmeyer K. Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020. Euro Surveill. 2020 02; 25(6). PMID: 32046815.
      Citations: 67     Fields:    Translation:HumansCellsPHPublic Health
    21. Reusken CB, Haagmans B, Meijer A, Corman VM, Papa A, Charrel R, Drosten C, Koopmans M. Authors' response: Plenty of coronaviruses but no SARS-CoV-2. Euro Surveill. 2020 02; 25(8). PMID: 32127125.
      Citations:    Fields:    Translation:CellsPHPublic Health
    22. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML, Mulders DG, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MP, Drosten C. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020 01; 25(3). PMID: 31992387.
      Citations: 2269     Fields:    Translation:HumansCellsPHPublic Health
    Reusken's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (283)
    Explore
    _
    Co-Authors (361)
    Explore
    _
    Similar People (60)
    Explore
    _